ALMKT:EPA
Mauna Kea Technologies SA
€०.०९१
arrow_downward
-१.६२%(-०.००१५) १ दि
६ नोव्हें, ५:३५:०४ PM [GMT]+१ · EUR
search
सर्व सिम्बॉल
| सिम्बॉल | किंमत | बदल | % बदल |
|---|
insights_autoALMKT साठी टॉप इनसाइट जनरेट करत आहे...
उघडा
€०.०८
उच्च
€०.०९
कमी
€०.०८
मार्केट कॅप
१.७८ कोटी
सरासरी उलाढाल
५.४९ लाख
उलाढाल
३.८६ लाख
P/E रेशो
०.७८
५२ आठवड्यांतील उच्चांक
€०.२३
५२ आठवड्यांतील नीचांक
€०.०७
EPS
€०.१२
थकित शेअर
१९.५३ कोटी
कर्मचाऱ्यांची संख्या
५६
उघडा
€०.०८
उच्च
€०.०९
कमी
€०.०८
मार्केट कॅप
१.७८ कोटी
सरासरी उलाढाल
५.४९ लाख
उलाढाल
३.८६ लाख
P/E रेशो
०.७८
५२ आठवड्यांतील उच्चांक
€०.२३
५२ आठवड्यांतील नीचांक
€०.०७
EPS
€०.१२
थकित शेअर
१९.५३ कोटी
कर्मचाऱ्यांची संख्या
५६
बातम्यांच्या स्टोरी
वेब स्रोत आणि बातमी भागीदारांकडून
BigGo Finance
·
१९ मिनिटांपूर्वी
Nasdaq Slides Into Correction as Fear Gauge Hits 'Extreme Fear'; Buffett's Crisis Playbook Back in Focus
Binance
·
६ मिनिटांपूर्वी
TradFi News | Nasdaq Drops 3.4% in Week as AI Chip Stocks Slump; Berkshire Posts Record $9.6 Billion Buyback
Yahoo Finance
·
१ दिवसापूर्वी
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
Investor's Business Daily
·
२ तासांपूर्वी
Futures Loom For Battered, Volatile Market; What To Do Now
प्रोफाइल
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA बद्दल
CEOसॅचा लोइसो
कर्मचारी५६
स्थापना२०००
मुख्यालये-
क्षेत्रHealth Care
उद्योगMedical device
वेबसाइटmaunakeatech.com